Supplements Shielded From Spread Of Peanut Butter-Like Problems – Trades
This article was originally published in The Tan Sheet
Executive Summary
Safeguards in place in the dietary supplement industry would prevent or quickly contain a crisis like the current spate of recalls of peanut butter-containing products now facing the food industry, supplement experts say
You may also be interested in...
Guidance for salmonella in peanut products
FDA issues guidance to assist manufacturers of products containing peanut ingredients in avoiding contamination by salmonella bacteria. The March 11 guidance advises firms to "obtain peanut-derived product only from suppliers with validated processes in place to adequately reduce the presence of salmonella." FDA suggests companies not rely on a history of negative microbiological tests for salmonella in finished peanut product, as this does not ensure the adequacy of a supplier's procedures for controlling bacteria. Peanut-containing products recalled recently in the salmonella outbreak include nutritional bars, though industry experts say dietary supplement ingredients generally do not harbor harmful bacteria (1"The Tan Sheet" Jan. 26, 2009, p. 8)
Ounce Of Prevention Would Have Saved Pounds Of Peanut Pain – Experts
The ripple effect of peanut recalls underscores the importance of steps firms in any industry segment must take to ensure their business partners are not undermining the integrity of the supply chain, experts say
Peanut Product Recalls Renew Questions On FDA’s Food Safety Capability
FDA's response to an outbreak of salmonella bacteria in peanut butter shows little evidence that the agency is capable of keeping the complex food supply safe, according to a former FDA executive